GEN-725

· Henan Genuine Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GEN-725, covering 2026-01-23 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ⅰ/Ⅱa Clinical Study of GEN-725 in Combination With Dositinib [Phase 1, Phase 2]